At MIHA, we design smarter, data-driven plans built around you
Cardiometabolic benefits: At 48 weeks, improvements included triglyceride reductions up to 40.6% and apoC-III reductions of 38%, along with substantial weight loss (24%) Post-hoc analysis uncovered reductions in albuminuria (3037%) and increased eGFR (8.5 mL/min/1.73 m), suggesting potential kidney-protective effects TRIUMPH-3 and TRIUMPH-OUTCOMES are ongoing Phase 3 studies targeting Cardiovascular safety and outcomes and Renal function in obese individuals with ASCVD or CKD Future with Other GLP-1 and GIP Analogues (Poly-agonists) The development of multi-receptor agonists like retatrutide is the next-generation leap beyond GLP-1 monotherapy, holding potential efficacy comparable to bariatric surgery with fewer GI limitations
Carnitine What is Carnitine
The production of glutathione relies on SAMe, which is produced through the methylation pathway
Konopleva M, Zhang W, Ling X, Samudio I, Y-Xi S, McQueen T, Tsao T, Meyer C, Munsell MF, Yu D, Safe SH, M-C H, Andreeff M
To find out if its a good fit, a healthcare provider can evaluate health history and goals to determine the most appropriate treatment plan
